☰
UnitedHealth Group, a US based for-profit managed health care firm, has reportedly acquired DivvyDose, an American start-up that helps patients suffering from chronic diseases get their prescription medicine delivered in pre-sorted packages....
iWEECARE, the company behind the smallest continuous temperature tracking product in the world, Temp Pal®, has reportedly announced that it raised over $2.4 million from an extended pre-series A investment round. The funding round was ....
Securitas, a Sweden based security services firm, has reportedly announced the acquisition of the electronic security businesses of US based security system provider, Stanley Security Solutions, located in Portugal, India, Singapore, Switze....
MGC Pharmaceuticals, a renowned EU based bio-pharmaceutical firm, has reportedly announced that it has expanded the double-blind, placebo-controlled phase II clinical trial that assesses the efficacy and safety of its anti-inflammatory natu....
Accenture, a renowned professional services company, has reportedly announced that it developed a data and analytics approach to derive and manage insights from the genomic data of pediatric AML (acute myeloid leukemia). Working alongside ....
Leading integrated payment and commerce solutions provider, Paya, has reportedly entered into a partnership with Software-as-a-Service application supplier, CoverMe. The collaboration will effectively help CoverMe in enhancing the efficienc....
Leading bio-production tools supplier, BioLife Solutions Inc, has reportedly signed a definitive agreement for the acquisition of biological materials storage provider, SciSafe. SciSafe is known for delivering biological materials storage t....
New Hampshire-based in-vitro diagnostics expert American Laboratory Products Co. Ltd. (ALPCO) recently announced the recapitalization of its enterprise by Ampersand Capital Partners, a middle market private equity firm. Sources with knowle....
Swiss-based multinational pharmaceutical company, Novartis has recently revealed detailed results from the Phase III COMBI-i study assessing spartalizumab (PDR001), the investigational biological therapy in combination with Mekinist®&nb....
CoreMap announced that it has accomplished $10.5 million Series A financing which was led by Qure Ventures. The round included both present investors like Ronny Ginor, and Orbimed Venture Partners and MD of Fifth Focus/HRMG Investments and ....
